It is a pharma private limited company based in Delhi, Delhi, India, established in 2022.
2022 | Delhi, Delhi, India | ActiveParrish Pharmaceutical Private Limited, a active private limited company, was established on 23 May 2022 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24239DL2022PTC398795. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹2.80 Cr.
It upholds a compliant status. Employing 9 professional, Its leadership includes Ravikant (Director), Priyanka (Director), Rohit Bhardwaj (Additional Director). Past directors included Ravikant, Arun . Saini, Sunil Kumar. It holds ₹4.95 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-33, F/F, Hari Nagar Extn Gali No. 2 Badarpur, Delhi, Delhi, 110044.
U24239DL2022PTC398795
398795
23 May 2022
₹4.00 Cr
₹2.80 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Parrish Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravikant | Director | 16 Jun 2022 | Current |
| Priyanka | Director | 23 May 2022 | Current |
| Rohit Bhardwaj | Additional Director | 01 Oct 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 02 Dec 2024 | Past |
| Pramod Abcsdd | Director | 02 Dec 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Parrish Pharmaceutical Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.71%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2024, Parrish Pharmaceutical had a public holding of 48.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹49,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2023 | State Bank Of India | ₹4.95 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Parrish Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Parrish Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parrish Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rohit Bhardwaj was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2025 & has been associated with this company since 2 months 25 days . was recorded as a recent event.
The activity Parrish Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Parrish Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity A charge with State Bank Of India amounted to Rs. 4.95 Cr with Charge ID 100698277 was registered on 20 Mar 2023. was completed.
Progress on Ravikant was appointed as a Director was appointed as a Director on 16 Jun 2022 & has been associated with this company since 3 years 6 months . was documented.
The activity Priyanka was appointed as a Director was appointed as a Director on 23 May 2022 & has been associated with this company since 3 years 7 months . was completed.
The CIN of Parrish Pharmaceutical Private Limited is U24239DL2022PTC398795.
Parrish Pharmaceutical Private Limited is headquartered at E-33, F/F, Hari Nagar Extn Gali No. 2 Badarpur, Delhi, Delhi, 110044.
Parrish Pharmaceutical Private Limited was incorporated on 23 May 2022.
The current directors of Parrish Pharmaceutical Private Limited are
The primary industry of Parrish Pharmaceutical Private Limited is Pharma.
Parrish Pharmaceutical Private Limited is unlisted.
The authorized capital of Parrish Pharmaceutical Private Limited is ₹4.00 Cr, and the paid-up capital is ₹2.80 Cr.
The compliance status of Parrish Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX